- Home
- AAOI vs ALEC Comparison
AAOI vs ALEC Comparison
Compare AAOI & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAOI
- ALEC
- Stock Information
- Founded
- AAOI 1997
- ALEC 2013
- Country
- AAOI United States
- ALEC United States
- Employees
- AAOI N/A
- ALEC N/A
- Industry
- AAOI Semiconductors
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AAOI Technology
- ALEC Health Care
- Exchange
- AAOI Nasdaq
- ALEC Nasdaq
- Market Cap
- AAOI 561.7M
- ALEC 487.7M
- IPO Year
- AAOI 2013
- ALEC 2019
- Fundamental
- Price
- AAOI $19.00
- ALEC $5.15
- Analyst Decision
- AAOI Buy
- ALEC Strong Buy
- Analyst Count
- AAOI 3
- ALEC 6
- Target Price
- AAOI $15.33
- ALEC $17.75
- AVG Volume (30 Days)
- AAOI 2.6M
- ALEC 535.7K
- Earning Date
- AAOI 11-07-2024
- ALEC 11-05-2024
- Dividend Yield
- AAOI N/A
- ALEC N/A
- EPS Growth
- AAOI N/A
- ALEC N/A
- EPS
- AAOI N/A
- ALEC N/A
- Revenue
- AAOI $206,944,000.00
- ALEC $55,275,000.00
- Revenue This Year
- AAOI $14.87
- ALEC N/A
- Revenue Next Year
- AAOI $78.81
- ALEC $96.01
- P/E Ratio
- AAOI N/A
- ALEC N/A
- Revenue Growth
- AAOI N/A
- ALEC N/A
- 52 Week Low
- AAOI $6.66
- ALEC $3.66
- 52 Week High
- AAOI $24.75
- ALEC $8.90
- Technical
- Relative Strength Index (RSI)
- AAOI 68.92
- ALEC 53.11
- Support Level
- AAOI $16.93
- ALEC $4.20
- Resistance Level
- AAOI $19.46
- ALEC $5.35
- Average True Range (ATR)
- AAOI 1.37
- ALEC 0.33
- MACD
- AAOI 0.27
- ALEC 0.07
- Stochastic Oscillator
- AAOI 92.42
- ALEC 82.68
About AAOI Applied Optoelectronics Inc.
Applied Optoelectronics Inc is a provider of fiber-optic networking products for the Internet data center, cable television, telecommunications and fiber-to-the-home end markets. The company focuses on designing and manufacturing a range of optical communication products from components, to subassemblies, and modules to complete turn-key equipment. Demand for Applied Optoelectronics is driven by bandwidth demand in end markets. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The company derives maximum revenue from Taiwan.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.